Shanghai - Delayed Quote CNY
Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
5.47
-0.09
(-1.62%)
At close: 3:00:02 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
634,356.90
602,615.33
600,095.34
545,369.15
527,440.66
Cost of Revenue
651,194.43
616,725.78
544,429.47
473,180.46
418,187.48
Gross Profit
-16,837.53
-14,110.45
55,665.88
72,188.70
109,253.18
Operating Expense
127,543.56
127,701.60
92,139.22
87,313.36
104,778.47
Operating Income
-144,381.10
-141,812.04
-36,473.35
-15,124.67
4,474.71
Net Non Operating Interest Income Expense
-29,859.27
-26,075.32
-22,347.38
-18,674.23
-10,884.67
Pretax Income
-210,788.70
-200,858.94
-148,519.22
-29,344.35
-30,685.74
Tax Provision
-10,655.07
-10,363.01
-1,230.26
-14,406.52
-7,647.64
Net Income Common Stockholders
-200,332
-190,668.98
-147,417.27
-14,648.70
-22,762.01
Basic EPS
-0.69
-0.66
-0.51
-0.05
-0.08
Diluted EPS
-0.69
-0.66
-0.51
-0.05
-0.08
Basic Average Shares
289,494.66
288,892.39
289,053.46
292,974.05
284,525.10
Diluted Average Shares
289,494.66
288,892.39
289,053.46
292,974.05
284,525.10
Total Operating Income as Reported
-206,720.29
-197,704.98
-146,821.45
-29,359.34
-28,073.61
Total Expenses
778,738
744,427.38
636,568.69
560,493.82
522,965.95
Net Income from Continuing & Discontinued Operation
-200,332
-190,668.98
-147,417.27
-14,648.70
-22,762.01
Normalized Income
-162,470.15
-155,580.47
-51,647.29
-8,070.46
-3,581.73
Interest Income
348.84
467.07
1,156.32
2,010.51
1,156.83
Interest Expense
31,192.10
26,426.20
23,187.79
20,177.30
11,798.84
Net Interest Income
-29,859.27
-26,075.32
-22,347.38
-18,674.23
-10,884.67
EBIT
-179,596.59
-174,432.74
-125,331.43
-9,167.05
-18,886.90
EBITDA
-179,596.59
-123,997.58
-70,662.67
32,445.25
10,152.54
Reconciled Cost of Revenue
651,194.43
616,725.78
544,429.47
473,180.46
418,187.48
Reconciled Depreciation
--
50,435.16
54,668.76
41,612.30
29,039.44
Net Income from Continuing Operation Net Minority Interest
-200,332
-190,668.98
-147,417.27
-14,648.70
-22,762.01
Total Unusual Items Excluding Goodwill
-39,877.60
-36,997.33
-96,569.91
-8,770.99
-25,547.29
Total Unusual Items
-39,877.60
-36,997.33
-96,569.91
-8,770.99
-25,547.29
Normalized EBITDA
-139,718.99
-87,000.25
25,907.24
41,216.24
35,699.83
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,015.76
-1,908.82
-799.94
-2,192.75
-6,367.01
12/31/2021 - 8/7/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade